Pin1: A therapeutic target in Alzheimer neurodegeneration

Journal of Molecular Neuroscience

Volumn 19, Issue 3, 2002, Pages 275-287

  Hamdane, Malika ^a   Smet, Caroline ^b   Sambo, Anne Véronique ^a   Leroy, Arnaud ^c   Wieruszeski, Jean Michel ^b   Delobel, Patrice ^a   Maurage, Claude Alain ^d   Ghestem, Antoine ^a   Wintjens, René ^b   Bégard, Séverine ^a   Sergeant, Nicolas ^a   Delacourte, André ^a   Horvath, Dragos ^e   Landrieu, Isabelle ^b   Lippens, Guy ^b   Buée, Luc ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e CEREP   (France)

Author keywords

Cell cycle; NMR spectroscopy; Phosphorylation; Rotamase; Tau proteins

Indexed keywords

CYCLIN D1; ISOMERASE; PEPTIDYLPROLYL ISOMERASE PIN1; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ALZHEIMER DISEASE; CELL LINE; CYCLIN D1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; NAPHTHOQUINONES; NEUROBLASTOMA; NEURONS; PEPTIDYLPROLYL ISOMERASE; PHOSPHOPYRUVATE HYDRATASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE; TAU PROTEINS;

EID: 0036926421     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:19:3:275     Document Type: Article

References (31)

1. Buée L., Bussière T., Buée-Scherrer V., Delacourte A., and Hof P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33, 95-130.
2. Delacourte A., David J.-P., Sergeant N., Buée L., Wattez A., Vermersch P., et al. (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52, 1158-1165.
3. Delobel P., Flament S., Hamdane M., Mailliot C., Sambo A. V., Bégard S., et al. (2002) Abnormal Tau phosphorylation of the Alzheimer-type is a mitotic phosphorylation. J. Neurochem., in press.
4. Hajduk P. J., Meadows R. P., and Fesik S. W. (1997) Discovering high-affinity ligands for proteins. Science 278, 497-499.
5. Hennig L., Christner C., Kipping M., Schelbert B., Rucknagel K. P., Grabley S., et al. (1998) Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37(17), 5953-5960.
6. Jicha G. A., Lane E., Vincent I., Otvos L. Jr., Hoffmann R., and Davies P. (1997) A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 69, 2087-2095.
7. Landrieu I., De Veylder L., Fruchart J. S., Odaert B., Casteels P., Portetelle D., et al. (2000) The Arabidopsis thaliana Pin1At gene encodes a single-domain phosphorylation-dependent peptidyl prolyl cis/trans isomerase. J. Biol. Chem. 275, 10,577-10,581.
8. Landrieu I., Wieruszeski J. M., Wintjens, R., Inzé D., and Lippens G. (2002) Solution structure of the single-domain prolyl cis/trans isomerase PIN1At from Arabidopsis thaliana. J. Mol. Biol. 320, 321-332.
9. Liu D. X. and Greene L. A. (2001) Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 305, 217-228.
10. Lu K. P., Hanes S. D., and Hunter T. (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380, 544-547.
11. Lu P. J., Zhou X. Z., Shen M., and Lu K. P. (1999a) Function of the WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283, 1325-1328.
12. Lu P. J., Wulf G., Zhou X. Z., Davies P., and Lu K. P. (1999b) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784-788.
13. Lu K. P., Liou Y.-C., and Zhou X. Z. (2002a) Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 12, 164-172.
14. Lu P. J., Zhou X. Z., Liou Y. C., Noel J. P., and Lu K. P. (2002b) Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 277, 2381-2384.
15. Mailliot C., Bussière T., Hamdane M., Sergeant N., Caillet-Boudin M. L., Delacourte A., et al. (2000) Pathological tau phenotypes: The weight of mutations, polymorphisms and differential neuronal vulnerabilities. Ann. NY Acad. Sci. 920, 107-114.
16. Nagy Z. (2000) Cell cycle regulatory failure in neurones: causes and consequences. Neurobiol. Aging 21, 761-769.
17. Ranganathan R., Lu K. P., Hunter T., and Noel J. P. (1997) Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89, 875-886.
18. Ryo A., Nakamura M., Wulf G., Liou Y. C., and Lu K. P. (2001) Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3, 793-801.
19. Sambrook J., Fritsch T., and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
20. Sergeant N., David J. P., Champain D., Ghestem A., Wattez A., and Delacourte A. (2002) Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease. J. Neurochem. 81, 663-672.
21. Shen M., Stukenberg P. T., Kirschner M. W., and Lu K. P. (1998) The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 12, 706-720.
22. Sherr C. J. and Roberts J. M. (1999) CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
23. Stukenberg P. T. and Kirschner, M. W. (2001) Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 7, 1071-1083.
24. Verdecia, M. A., Bowman, M. E., Lu, K. P., Hunter, T., and Noël, J. P. (2000) Structural basis for phosphoserineproline recognition by group IV WW domains. Nat. Struct. Biol. 7, 639-643.
25. Vincent I., Rosado M., and Davies P. (1996) Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132, 413-425.
26. Wintjens R., Wieruszeski J. M., Drobecq H., Rousselot-Pailley P., Buée L., Lippens G., et al. (2001) 1H NMR study on the binding of Pin1 WW domain with phosphothreonine peptides. J. Biol. Chem. 276, 25,150-25,156.
27. Wulf G. M., Ryo A., Wulf G. G., Lee S. W., Niu T., Petkova V., et al. (2001) Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20, 3459-3472.
28. Yaffe M. B., Schutkowski M., Shen M., Zhou X. Z., Stukenberg P. T., Rahfeld J. U., et al. (1997) Sequence-specific and phosphorylation-dependent proline isomerization: A potential mitotic regulatory mechanism. Science 278, 1957-1960.
29. You H., Zheng H., Murray S. A., Yu Q., Uchida T., Fan D., et al. (2002) IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J. Cell Biochem. 84, 211-216.
30. Zhou X. Z., Lu P. J., Wulf G., and Lu K. P. (1999) Phosphorylation-dependent prolyl isomerization: A novel signaling regulatory mechanism. Cell. Mol. Life Sci. 56, 788-806.
31. Zhou X. Z., Kops O., Werner A., Lu P. J., Shen M., Stoller G., et al. (2000) Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6, 873-883.